Last 22 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 3.99 | — | — | — | — | 16.05 | 12.58 | 10.10 | 19.20 | 29.35 | — | — | 22.43 |
| — | — | — | — | — | -45.3% | — | — | -14.4% | -65.2% | — | — | +91.9% | |
| P/S Ratio | 0.12 | 0.56 | 0.48 | 0.70 | 0.89 | 0.64 | 0.50 | 0.57 | 0.73 | 0.75 | 1.93 | 1.96 | 1.66 |
| — | -12.7% | -3.0% | +22.4% | +22.5% | -15.2% | -74.2% | -70.9% | -56.1% | -70.6% | +2.9% | -13.5% | -13.8% | |
| P/B Ratio | 0.25 | 0.60 | 0.54 | 0.89 | 1.37 | 1.09 | 1.03 | 1.39 | 1.91 | 1.92 | 3.42 | 3.13 | 2.60 |
| — | -44.4% | -47.8% | -36.2% | -28.1% | -43.4% | -69.8% | -55.5% | -26.6% | -51.2% | +5.7% | -29.8% | -37.1% | |
| P/FCF | 1.13 | 388.70 | 1.21 | 8.97 | 8.84 | 2.98 | 2.34 | — | — | — | 28.27 | — | — |
| — | +12935.8% | -48.3% | — | — | — | -91.7% | — | — | — | +52.5% | — | — | |
| EV / EBITDA | 0.92 | — | — | — | — | 5.60 | 5.50 | 5.60 | 8.73 | 10.12 | 40.78 | — | 43.24 |
| — | — | — | — | — | -44.7% | -86.5% | — | -79.8% | -68.1% | +142.2% | — | +278.1% | |
| EV / EBIT | 1.43 | — | — | — | — | 7.90 | 7.83 | 6.98 | 12.18 | 15.15 | 139.92 | — | 1830.55 |
| — | — | — | — | — | -47.9% | -94.4% | — | -99.3% | -72.2% | +552.6% | — | +14443.2% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
DocGo Inc.'s operating margin was -59.3% in Q3 2025, down 37.5 pp QoQ and down 66.6 pp YoY. This marks the 5th consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of -25.4% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 28.9% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 34.6% | 25.6% | 31.6% | 32.1% | 33.5% | 36.0% | 33.9% | 35.0% | 33.5% | 29.5% | 33.4% | 28.1% | 39.0% |
| — | -28.9% | -6.7% | -8.3% | +0.1% | +22.0% | +1.5% | +24.6% | -14.1% | -6.9% | -7.1% | -16.9% | -4.3% | |
| Operating Margin | 4.7% | -59.3% | -21.7% | -14.6% | -6.2% | 7.3% | 6.2% | 8.3% | 5.9% | 4.7% | 1.3% | -6.1% | 0.1% |
| — | -911.0% | -453.3% | -276.4% | -205.6% | +56.6% | +389.9% | +235.3% | +7860.5% | +16.0% | -81.6% | -171.3% | -99.4% | |
| Net Margin | 3.2% | -39.2% | -13.9% | -9.8% | -2.7% | 4.0% | 4.0% | 5.8% | 3.8% | 2.6% | -1.6% | -3.1% | 7.4% |
| — | -1089.2% | -450.4% | -267.6% | -171.1% | +55.2% | +347.0% | +290.6% | -48.7% | -15.5% | -113.8% | -134.0% | -61.8% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 6.4% | -10.1% | -3.8% | -3.0% | -1.0% | 1.7% | 2.1% | 3.6% | 2.5% | 1.7% | -0.7% | -1.2% | 2.9% |
| — | -692.1% | -283.4% | -184.2% | -140.2% | +3.3% | +391.2% | +394.0% | -13.5% | +37.9% | -113.8% | -127.1% | -81.7% | |
| ROA | 4.2% | -7.3% | -2.7% | -2.1% | -0.7% | 1.1% | 1.3% | 2.3% | 1.7% | 1.2% | -0.5% | -0.9% | 2.2% |
| — | -750.9% | -299.3% | -192.7% | -141.3% | -4.8% | +364.6% | +364.4% | -22.7% | +28.2% | -113.0% | -125.8% | -79.3% | |
| ROIC | 7.5% | -13.7% | -5.0% | -3.7% | -1.9% | 2.5% | 2.4% | 3.9% | 3.2% | 2.9% | 0.6% | -3.2% | 0.0% |
| — | -637.0% | -306.0% | -196.2% | -161.4% | -11.4% | +287.3% | +221.2% | +6854.4% | -12.2% | -92.2% | -128.7% | -99.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has improved 18.3% YoY to 2.59x, strengthening the short-term liquidity position.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.18 | 0.11 | 0.21 | 0.20 | 0.18 | 0.18 | 0.17 | 0.17 | 0.15 | 0.07 | 0.07 | 0.07 | 0.07 |
| — | -35.6% | +25.5% | +21.7% | +19.1% | +141.6% | +131.0% | +130.3% | +113.4% | -4.4% | +25.8% | +3.8% | -1.8% | |
| Debt / EBITDA | 1.28 | — | — | — | — | 3.98 | 3.71 | 2.60 | 2.85 | 1.62 | 3.80 | — | 5.87 |
| — | — | — | — | — | +145.4% | -2.5% | — | -51.4% | -43.1% | +146.6% | — | +504.9% | |
| Current Ratio | 2.50 | 2.59 | 2.36 | 2.44 | 2.50 | 2.19 | 2.13 | 2.09 | 1.99 | 2.36 | 2.56 | 2.37 | 2.71 |
| — | +18.3% | +10.8% | +16.6% | +25.5% | -7.5% | -16.5% | -11.7% | -26.4% | -33.3% | -46.3% | -46.1% | -38.8% | |
| Quick Ratio | 2.50 | 2.59 | 2.36 | 2.44 | 2.50 | 2.19 | 2.13 | 2.09 | 1.99 | 2.36 | 2.56 | 2.37 | 2.66 |
| — | +18.3% | +10.8% | +16.6% | +25.5% | -7.5% | -16.5% | -11.7% | -25.2% | -33.3% | -46.3% | -46.1% | -39.8% | |
| Interest Coverage | 13.24 | -190.92 | -39.40 | -32.84 | -13.80 | 20.07 | 19.76 | 43.02 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 22 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonDocGo Inc.'s current P/E is 4.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
DocGo Inc.'s current operating margin is 4.7%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking DocGo Inc.'s business trajectory between earnings reports.